NCT04217200

Brief Summary

Earlier studies describe the half-life of hPL in serum as being ninety minutes and that the hormone is excreted unchanged in urine; consequently, there is real potential to use the fall in hormone levels in urine to monitor bleeding in pregnancy, the outcome of natural and artificial abortions or placental health. This study will focus on the fall of hPL following delivery by Caesarean section when women have a urinary catheter in place and sampling urine is simple to achieve.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2018

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

January 3, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

February 19, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2020

Completed
Last Updated

June 22, 2020

Status Verified

June 1, 2020

Enrollment Period

1 month

First QC Date

August 16, 2018

Last Update Submit

June 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The rate of change in human placental lactogen concentration in urine post delivery by Caesarian section

    Baseline and then 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 & 360 minutes after delivery of the baby by Caesarean section

Eligibility Criteria

Age18 Years - 52 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women with a singleton pregnancy presenting for a Caesarean section delivery

You may qualify if:

  • The women is 18 years of age or older
  • She understands the patient information leaflet, trial requirements and has signed the consent form
  • The Caesarean delivery will be at GSTFT
  • Prepared for urine to be collected for up to when the urinary catheter is removed or six hours, whichever is sooner
  • Agrees for the demographic and medical history data to be collected.

You may not qualify if:

  • Under 18 years of age
  • Unable to understand the patient information leaflet or consent to join the trial
  • The Caesarean delivery will not be at GSTFT
  • The women is not for urine to be collected
  • The women does not agree for demographic or history data to be collected.
  • The women has a haemorrhage greater than one litre during the Caesarean delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guy's & St Thomas' NHS Foundation Trust

London, England, SE1 7AB, United Kingdom

Location

Related Publications (1)

  • Whittaker PG, Lind T, Lawson JY. A prospective study to compare serum human placental lactogen and menstrual dates for determining gestational age. Am J Obstet Gynecol. 1987 Jan;156(1):178-82. doi: 10.1016/0002-9378(87)90233-x.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Urine

MeSH Terms

Conditions

Abortion, Threatened

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Anatole S Menon-Johansson, PhD,MPH,FRCP

    Guy's and St Thomas' NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Clinical Lead, Sexual & Reproductive Health Department

Study Record Dates

First Submitted

August 16, 2018

First Posted

January 3, 2020

Study Start

February 19, 2020

Primary Completion

March 26, 2020

Study Completion

March 26, 2020

Last Updated

June 22, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

All samples will be labelled with a trial identifier when they are sent to the laboratory for analysis. Only the PI will know the link between the trial identifier and the patient clinic number. The patient clinic number can only be linked to an identifiable patient by staff who have access to the hospital electronic patient record.

Locations